Introduction to NDC 72865-0148
NDC 72865-0148 corresponds to Losartan Potassium, a medication classified under the category of Angiotensin 2 Receptor Antagonists. This drug is manufactured and distributed by XLCare Pharmaceuticals, Inc.[1].
Drug Overview
Losartan Potassium is a film-coated oral tablet used primarily to treat high blood pressure (hypertension) and to protect the kidneys from damage due to diabetes. It works by blocking the action of angiotensin II, a potent vasoconstrictor, which is part of the renin-angiotensin-aldosterone system (RAAS) that regulates blood pressure.
Market Context
The pharmaceutical market for antihypertensive drugs is highly competitive and dynamic. Losartan Potassium, being a generic version of the brand-name drug Cozaar, benefits from the generic drug market's growth. Generic drugs typically offer significant cost savings compared to their brand-name counterparts, making them more accessible to a wider patient population.
Pricing Trends
Pricing trends for generic drugs like Losartan Potassium can be influenced by several factors, including market competition, regulatory changes, and supply chain dynamics.
- Historical Pricing: While specific historical pricing data for NDC 72865-0148 is not readily available, generic drugs generally see stable or slightly decreasing prices over time due to increased competition.
- Market Competition: The presence of multiple manufacturers for Losartan Potassium contributes to competitive pricing. This competition often leads to lower prices as manufacturers aim to capture market share.
- Regulatory Influences: Regulatory changes, such as updates to the FDA's National Drug Code (NDC) directory, can impact pricing transparency and competition. The FDA's efforts to ensure comprehensive and updated listings of all marketed drugs help maintain a competitive market environment[4].
Price Projections
Given the trends in the pharmaceutical industry, here are some key points to consider for price projections:
- Stability in Pricing: Generic drugs like Losartan Potassium tend to have stable prices due to the competitive nature of the generic drug market. However, minor fluctuations can occur based on production costs, raw material prices, and market demand.
- Potential Decreases: As more manufacturers enter the market, prices may decrease slightly to maintain competitiveness. This is a common trend observed in the generic pharmaceutical sector.
- Impact of Inflation and Economic Factors: Economic conditions, including inflation, can influence the pricing of pharmaceuticals. However, the impact is usually minimal on generic drugs compared to brand-name medications.
Market Analysis
Demand and Supply
The demand for antihypertensive medications like Losartan Potassium remains high due to the prevalence of hypertension and related conditions. The supply side is well-supported by multiple manufacturers, ensuring a stable market.
Competitive Landscape
The competitive landscape for Losartan Potassium includes several other generic manufacturers. This competition drives pricing strategies and ensures that prices remain competitive.
Regulatory Environment
The FDA's regulatory framework plays a crucial role in maintaining market transparency and competition. The updated NDC directory, which includes all electronically listed drugs in their final marketed form, helps in monitoring and regulating the market effectively[4].
Key Takeaways
- Stable Pricing: Losartan Potassium is likely to maintain stable prices due to the competitive generic drug market.
- Minor Fluctuations: Prices may see minor decreases or increases based on market dynamics and economic factors.
- Regulatory Influence: The FDA's regulatory efforts ensure a transparent and competitive market environment.
- High Demand: The demand for antihypertensive medications remains high, supporting a stable market for Losartan Potassium.
FAQs
1. What is the primary use of Losartan Potassium (NDC 72865-0148)?
Losartan Potassium is primarily used to treat high blood pressure (hypertension) and to protect the kidneys from damage due to diabetes.
2. Who manufactures and distributes Losartan Potassium under NDC 72865-0148?
Losartan Potassium under NDC 72865-0148 is manufactured and distributed by XLCare Pharmaceuticals, Inc.[1].
3. How does the competitive landscape affect the pricing of Losartan Potassium?
The competitive landscape, with multiple manufacturers producing Losartan Potassium, drives pricing strategies and ensures that prices remain competitive.
4. What regulatory factors influence the pricing and market of Losartan Potassium?
The FDA's regulatory framework, including the updated NDC directory, plays a crucial role in maintaining market transparency and competition, which influences pricing and market dynamics[4].
5. What can be expected in terms of price projections for Losartan Potassium?
Prices for Losartan Potassium are likely to remain stable with potential minor decreases due to market competition and economic factors.
Sources
- FDA.report: NDC 72865-143 Oral Tablet, Film Coated LOSARTAN POTASSIUM.
- Missouri Department of Social Services: Jan-2023 MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price.
- DrugPatentWatch: Latest drug prices and trends for NDC 72819-0160.
- YouTube: NDC Directory (March 2015).
- DrugPatentWatch: Latest pharmaceutical drug prices and trends for NDC 00054-4858.
